Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP905688.RAXLGUF9C0jzrc33thTtbwap4hLI05vc7eq8dKusgJ9LE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP905688.RAXLGUF9C0jzrc33thTtbwap4hLI05vc7eq8dKusgJ9LE130_assertion type Assertion NP905688.RAXLGUF9C0jzrc33thTtbwap4hLI05vc7eq8dKusgJ9LE130_head.
- NP905688.RAXLGUF9C0jzrc33thTtbwap4hLI05vc7eq8dKusgJ9LE130_assertion description "[Among the patients with myelofibrosis, those with ASXL1 lesions were not distinguished from their wild-type counterparts with regard to JAK2 V617F status, exposure to chemotherapy or evolution to leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905688.RAXLGUF9C0jzrc33thTtbwap4hLI05vc7eq8dKusgJ9LE130_provenance.
- NP905688.RAXLGUF9C0jzrc33thTtbwap4hLI05vc7eq8dKusgJ9LE130_assertion evidence source_evidence_literature NP905688.RAXLGUF9C0jzrc33thTtbwap4hLI05vc7eq8dKusgJ9LE130_provenance.
- NP905688.RAXLGUF9C0jzrc33thTtbwap4hLI05vc7eq8dKusgJ9LE130_assertion SIO_000772 21712540 NP905688.RAXLGUF9C0jzrc33thTtbwap4hLI05vc7eq8dKusgJ9LE130_provenance.
- NP905688.RAXLGUF9C0jzrc33thTtbwap4hLI05vc7eq8dKusgJ9LE130_assertion wasDerivedFrom befree-2016 NP905688.RAXLGUF9C0jzrc33thTtbwap4hLI05vc7eq8dKusgJ9LE130_provenance.
- NP905688.RAXLGUF9C0jzrc33thTtbwap4hLI05vc7eq8dKusgJ9LE130_assertion wasGeneratedBy ECO_0000203 NP905688.RAXLGUF9C0jzrc33thTtbwap4hLI05vc7eq8dKusgJ9LE130_provenance.